Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. Dr. Solomon explains
49,234
Published 2020-02-19
Dr. Solomon and his colleagues looked at data on 4,786 participants from CIRT who were randomized to receive low-dose methotrexate with folate or a placebo. Of 2,391 subjects who received methotrexate, 87 percent experienced an adverse event of interest compared to 81.5 percent of those who were randomized to placebo.
Dr. Solomon explains the results in this video.